Mikhail Markovich Gusyatiner

This inventor holds 46 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 17 EPO patents, primarily in Amino Acid Production. Top assignees: Ajinomoto Co., Ltd., Ajinomoto., Inc., Other. Active years: 1981-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mikhail Markovich Gusyatiner. Retrieved from https://idiyas.com/inventor/mikhail-markovich-gusyatiner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 46 (Patent Applications = 4)

% Patents Active = 60.9

CIPO Patents = 1

EPO Patents = 17 (Patent Applications = 10)

Average Co-Inventor Count = 6.1

ph-index = 13

Forward Citations = 530(Granted Patents)

Location History:

Moscow, SU (1981 - 1999)
Moscow, RU (1996 - 2017)

Company Filing History:

2 out of 834,570

Other

patents

Years Active: 1981-2017

Loading Chart...

Areas of Expertise:

L-Amino Acids

Enterobacteriaceae

L-Arginine

L-Glutamic Acid

Fermentation

Bacterium

Mutant Enzymes

Xylose Utilization

Bacterial Strain

Escherichia Coli

L-Proline

L-Valine

46 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9840725 - [object Object] (2017-12-12),

2. 9029104 - Method for producing an L-amino acid belonging to the glutamate family, using a coryneform bacterium (2015-05-12),

3. 8785161 - Method for producing L-amino acids using bacteria of the enterobacteriaceae family (2014-07-22),

4. 8728774 - Method for producing L-amino acids using bacteria of the enterobacteriaceae family (2014-05-20),

5. 8722370 - Method for producing an L-amino acid using a bacterium of the enterobacteriaceae family, having attenuated expression of gene(s) encoding peptidase (2014-05-13),

6. 8703446 - Method for producing an L-amino acid using a bacterium of the Enterobacteriaceae family (2014-04-22),

7. 8691537 - [object Object] (2014-04-08),

8. 8647838 - Method for producing L-arginine using a bacterium of enterobacteriaceae family, having attenuated expression of a gene encoding an L-arginine transporter (2014-02-11),

9. 8227214 - [object Object] (2012-07-24),

10. 8114639 - Method for producing an L-amino acid using a bacterium of the enterobacteriaceae family with attenuated expression of the sfmACDFH-fimZ cluster or the fimZ gene (2012-02-14),

11. 8088606 - [object Object] (2012-01-03),

12. 8003368 - Method for producing L-amino acids by fermentation using bacteria having enhanced expression of xylose utilization genes (2011-08-23),

13. 8003367 - Method for producing L-amino acids by fermentation using bacteria having enhanced expression of xylose utilization genes (2011-08-23),

14. 7919283 - Method for producing an L-amino acid using a bacterium of the enterobacteriaceae family with attenuated expression of any of the cynT, cynS, cynX or cynR gene or combination thereof (2011-04-05),

15. 7915018 - Method for producing L-amino acids using bacteria of the Enterobacteriaceae family (2011-03-29),

Title: Mikhail Markovich Gusyatiner - Innovative Inventor from Moscow

Introduction: Mikhail Markovich Gusyatiner is a renowned inventor hailing from Moscow, Russia, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Gusyatiner holds several patents in the areas of robotics, artificial intelligence, and renewable energy, showcasing his continuous dedication to innovation.

Career Highlights: With a career spanning over two decades, Gusyatiner has worked with leading research institutions and universities to develop cutting-edge technologies that have revolutionized the industry.

Collaborations: Throughout his career, Gusyatiner has collaborated with top companies and inventors worldwide, fostering a culture of creativity and excellence in the field of invention.

Conclusion: Mikhail Markovich Gusyatiner's passion for innovation and his relentless pursuit of technological advancement have solidified his position as a visionary inventor in the global landscape of inventions.

Profile summary based on public USPTO records.